Literature DB >> 3578545

Hepatic plasma flow: accuracy of estimation from bolus injections of indocyanine green.

F J Burczynski, K L Pushka, D S Sitar, C V Greenway.   

Abstract

Experiments were performed to determine the validity of the indocyanine green (ICG) clearance technique, with and without allowances for incomplete hepatic extraction, as an estimate of hepatic plasma flow. This technique was compared with that of directly measured hepatic blood flow using a hepatic venous long-circuit preparation in the anesthetized cat. This preparation allowed direct measurement and alteration of hepatic blood flow and collection of arterial, portal, and hepatic venous blood samples without depletion of the animal's blood volume. Measurements of ICG by spectrophotometry and high-pressure liquid chromatography (HPLC) were equally accurate, but the HPLC was 100 times more sensitive and allowed smaller sample volumes. It was determined that systemic clearance of ICG after a bolus dose (1.3 mumol/kg) was much smaller than hepatic blood flow. Allowance must be made for the incomplete extraction. When the clearance was multiplied by extraction, mean estimated hepatic plasma flow exceeded the measured flow values by 20-30%, and this difference was attributed to temporary extrahepatic distribution. In all experiments estimated hepatic plasma flows were highly variable, and reasons for this are discussed. In hepatectomized cats ICG was found to be distributed into extrahepatic tissues.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3578545     DOI: 10.1152/ajpheart.1987.252.5.H953

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Pharmacokinetics of drugs in cystic fibrosis.

Authors:  M Spino
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

2.  Effect of propranolol on portal vein hemodynamics: assessment by duplex sonography and indocyanine green clearance in healthy volunteers.

Authors:  W G Zoller; D R Wagner; J Zentner
Journal:  Clin Investig       Date:  1993-08

3.  Plasma disappearance of indocyanine green: a marker for excretory liver function?

Authors:  Alexander Stehr; Franz Ploner; Karl Traeger; Marc Theisen; Carl Zuelke; Peter Radermacher; Martin Matejovic
Journal:  Intensive Care Med       Date:  2005-10-18       Impact factor: 17.440

4.  Hepatic blood flow measurements and indocyanine green kinetics in a chronic dog model.

Authors:  A Skerjanec; D W O'Brien; T K Tam
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

5.  The kinetics of continuously infused indocyanine green in the pig.

Authors:  P Ott; L Bass; S Keiding
Journal:  J Pharmacokinet Biopharm       Date:  1996-02

6.  Indocyanine green plasma disappearance rate during the anhepatic phase of orthotopic liver transplantation.

Authors:  Lukas Bruegger; Peter Studer; Stefan W Schmid; Gunther Pestel; Juerg Reichen; Christian Seiler; Daniel Candinas; Daniel Inderbitzin
Journal:  J Gastrointest Surg       Date:  2007-10-25       Impact factor: 3.452

7.  Influence of hepatic regeneration after partial hepatectomy on theophylline pharmacokinetics in rats.

Authors:  A M Maza; A R Gascon; R M Hernandez; M A Solinis; M B Calvo; J L Pedraz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.569

Review 8.  Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update.

Authors:  Federico Ravaioli; Marco Montagnani; Andrea Lisotti; Davide Festi; Giuseppe Mazzella; Francesco Azzaroli
Journal:  Gastroenterol Res Pract       Date:  2018-06-07       Impact factor: 2.260

9.  The technique of 3D reconstruction combining with biochemistry to build an equivalent formula of indocyanine green (ICG) clearance test to assess the liver reserve function.

Authors:  Jinli Zheng; Wei Xie; Yang Huang; Yunfeng Zhu; Li Jiang
Journal:  BMC Surg       Date:  2020-11-12       Impact factor: 2.102

10.  Indocyanine Green Retention Test as a Predictor of Postoperative Complications in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.

Authors:  Rong-Yun Mai; Tao Bai; Xiao-Ling Luo; Guo-Bin Wu
Journal:  Ther Clin Risk Manag       Date:  2022-08-02       Impact factor: 2.755

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.